[
    [
        {
            "time": "",
            "original_text": "君实生物五年多亏超30亿，遭质疑或影响主打产品医保谈判，亏损",
            "features": {
                "keywords": [
                    "君实生物",
                    "亏损",
                    "医保谈判",
                    "质疑"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "君实生物五年多亏超30亿，遭质疑或影响主打产品医保谈判，亏损",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【浙商医药|周报】估值持续回落，mRNA疫苗积极结果导致板块分化",
            "features": {
                "keywords": [
                    "浙商医药",
                    "mRNA疫苗",
                    "估值回落",
                    "板块分化"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【浙商医药|周报】估值持续回落，mRNA疫苗积极结果导致板块分化",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "招商策略：中期A股有望迎来一轮明显的“跨年行情”",
            "features": {
                "keywords": [
                    "招商策略",
                    "A股",
                    "跨年行情"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "A股"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "招商策略：中期A股有望迎来一轮明显的“跨年行情”",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "君实生物深夜回复交易所问询，港股股价收盘已转涨，问询",
            "features": {
                "keywords": [
                    "君实生物",
                    "问询",
                    "港股",
                    "股价转涨"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "君实生物深夜回复交易所问询，港股股价收盘已转涨，问询",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【中金医药】疫苗突破+美国大选进展，行业调整与继续分化 - 中金医药周报系列七十九",
            "features": {
                "keywords": [
                    "中金医药",
                    "疫苗突破",
                    "美国大选",
                    "行业调整",
                    "分化"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【中金医药】疫苗突破+美国大选进展，行业调整与继续分化 - 中金医药周报系列七十九",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "高瓴加持也烫手？君实生物遭质疑股价大跌，市值蒸发超500亿，连续下跌",
            "features": {
                "keywords": [
                    "高瓴",
                    "君实生物",
                    "质疑",
                    "股价大跌",
                    "市值蒸发"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴加持也烫手？君实生物遭质疑股价大跌，市值蒸发超500亿，连续下跌",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【华泰金工林晓明团队】华夏养老2045今年以来收益38%——FOF投资周报20201115",
            "features": {
                "keywords": [
                    "华泰金工",
                    "华夏养老2045",
                    "FOF投资",
                    "收益38%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "养老基金",
                    "FOF"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【华泰金工林晓明团队】华夏养老2045今年以来收益38%——FOF投资周报20201115",
                "Correlation": 2,
                "Sentiment": 7,
                "Importance": 4,
                "Impact": 3,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "医药行业每周医览药闻：中国科技创新的卖水者，科学服务行业方兴未艾",
            "features": {
                "keywords": [
                    "医药行业",
                    "科技创新",
                    "科学服务",
                    "方兴未艾"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "科学服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业每周医览药闻：中国科技创新的卖水者，科学服务行业方兴未艾",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "生物医药行业周报：辉瑞新冠疫苗保护率超90%，新冠疫苗研发稳定推进",
            "features": {
                "keywords": [
                    "生物医药",
                    "辉瑞",
                    "新冠疫苗",
                    "保护率90%",
                    "研发推进"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "生物医药行业周报：辉瑞新冠疫苗保护率超90%，新冠疫苗研发稳定推进",
                "Correlation": 7,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]